Hebei Changshan Biochem Pharma (300255) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.021x

Based on the latest financial reports, Hebei Changshan Biochem Pharma (300255) has a cash flow conversion efficiency ratio of -0.021x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-30.86 Million ≈ $-4.52 Million USD) by net assets (CN¥1.48 Billion ≈ $216.35 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Hebei Changshan Biochem Pharma defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Hebei Changshan Biochem Pharma - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how Hebei Changshan Biochem Pharma's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Hebei Changshan Biochem Pharma Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hebei Changshan Biochem Pharma ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sichuan Chemical Co Ltd SHE:000155	0.057x
FADU Inc. KQ:440110	-0.122x
Shandong Dongyue Organosilicon Mat SHE:300821	-0.009x
International Seaways Inc NYSE:INSW	0.072x
Westgold Resources Ltd AU:WGX	0.250x
Suzhou Zelgen Biopharmaceuticals Co Ltd SHG:688266	0.000x
Cofinimmo SA BR:COFB	0.014x
Weihai Guangwei Composites Co Ltd SHE:300699	-0.003x

Annual Cash Flow Conversion Efficiency for Hebei Changshan Biochem Pharma (2008–2024)

The table below shows the annual cash flow conversion efficiency of Hebei Changshan Biochem Pharma from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see Hebei Changshan Biochem Pharma (300255) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.54 Billion ≈ $224.73 Million	CN¥56.22 Million ≈ $8.23 Million	0.037x	+95.34%
2023-12-31	CN¥1.80 Billion ≈ $263.35 Million	CN¥33.73 Million ≈ $4.94 Million	0.019x	+1731.13%
2022-12-31	CN¥3.05 Billion ≈ $446.90 Million	CN¥3.13 Million ≈ $457.36K	0.001x	+9.49%
2021-12-31	CN¥3.07 Billion ≈ $449.55 Million	CN¥2.87 Million ≈ $420.19K	0.001x	+101.45%
2020-12-31	CN¥2.85 Billion ≈ $417.52 Million	CN¥-183.58 Million ≈ $-26.86 Million	-0.064x	-201.33%
2019-12-31	CN¥2.72 Billion ≈ $398.35 Million	CN¥-58.13 Million ≈ $-8.51 Million	-0.021x	-118.40%
2018-12-31	CN¥2.52 Billion ≈ $369.20 Million	CN¥292.81 Million ≈ $42.85 Million	0.116x	+74.17%
2017-12-31	CN¥2.44 Billion ≈ $356.37 Million	CN¥162.28 Million ≈ $23.75 Million	0.067x	-11.29%
2016-12-31	CN¥2.29 Billion ≈ $335.01 Million	CN¥171.96 Million ≈ $25.16 Million	0.075x	+409.43%
2015-12-31	CN¥1.57 Billion ≈ $229.92 Million	CN¥-38.14 Million ≈ $-5.58 Million	-0.024x	+59.24%
2014-12-31	CN¥1.43 Billion ≈ $208.80 Million	CN¥-84.97 Million ≈ $-12.43 Million	-0.060x	-402.15%
2013-12-31	CN¥1.29 Billion ≈ $188.11 Million	CN¥-15.24 Million ≈ $-2.23 Million	-0.012x	+81.10%
2012-12-31	CN¥1.13 Billion ≈ $164.72 Million	CN¥-70.62 Million ≈ $-10.33 Million	-0.063x	-463.52%
2011-12-31	CN¥987.45 Million ≈ $144.49 Million	CN¥17.04 Million ≈ $2.49 Million	0.017x	-87.05%
2010-12-31	CN¥219.39 Million ≈ $32.10 Million	CN¥29.25 Million ≈ $4.28 Million	0.133x	-12.34%
2009-12-31	CN¥159.19 Million ≈ $23.30 Million	CN¥24.21 Million ≈ $3.54 Million	0.152x	+146.09%
2008-12-31	CN¥93.43 Million ≈ $13.67 Million	CN¥-30.83 Million ≈ $-4.51 Million	-0.330x	--

About Hebei Changshan Biochem Pharma

SHE:300255 China Biotechnology

Market Cap

$3.48 Billion

CN¥23.76 Billion CNY

Market Cap Rank

#4592 Global

#796 in China

Share Price

CN¥25.85

Change (1 day)

+3.73%

52-Week Range

CN¥24.92 - CN¥69.80

All Time High

CN¥69.80